ESC Professional Premium Access

Impact of sodium-glucose cotransporter-2 (SLGT2) inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac devices.

Congress Presentation

About the speaker

Doctor Enrique Sanchez Munoz

Hospital of Leon, Leon (Spain)
1 presentation
0 follower

5 more presentations in this session

High-power short-duration ablation of the atrioventricular node

Speaker: Doctor M. Alsaiqali (Sioux Falls, US)

Thumbnail

Risk of stiff left atrial syndrome following pulse-field-based ablation of atrial fibrillation in patients with pulmonary hypertension at baseline

Speaker: Doctor S. Mohanty (Austin, US)

Thumbnail

A comparison of general anesthesia versus monitored anesthesia care during catheter ablation for ventricular tachycardia

Speaker: Ms T. Woelber (Rochester, US)

Thumbnail

Atypical flutter: effectiveness of a systematic strategy based on comprehensive high-density map analysis

Speaker: Doctor J. Brito (Lisbon, PT)

Thumbnail

Risk of complications in patients undergoing pulmonary vein antrum isolation: a single centre experience

Speaker: Doctor M. Pirbaglou (Newmarket, CA)

Thumbnail

Access the full session

Update on EP studies, anti-arrhythmic drugs, and ablation techniques

Speakers: Doctor E. Sanchez Munoz, Doctor M. Alsaiqali, Doctor S. Mohanty, Ms T. Woelber, Doctor J. Brito...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb